Cardiometabolic Dataset

Cardiometabolic Biomarker Panel

De-identified cardiometabolic biobank cohort with proteomic, clinical, and longitudinal data for cardiovascular and metabolic disease research. Designed with HIPAA Safe Harbor de-identification standards, with full consent chain documentation for licensing.

Request This Dataset

Dataset specifications

This collection links proteomic panel data (Olink / SomaScan-compatible formats) with structured clinical lab results, EHR-derived phenotypes, and longitudinal outcome records up to 60 months. Cohort composition spans cardiovascular risk stratification, metabolic syndrome characterization, and type 2 diabetes subjects. All records are de-identified per HIPAA Safe Harbor method, QC-validated for batch effects and missingness, and consent-verified before catalog inclusion.

Available modalities

  • Proteomic panel (Olink/SomaScan)
  • Clinical labs
  • EHR phenotyping
  • Longitudinal outcomes

Common research indications

  • Cardiovascular risk stratification
  • Metabolic syndrome characterization
  • Type 2 diabetes cohorts
Request Dataset View Data Standards
Dataset metadata
Sample range1,200–4,500 subjects
De-identificationHIPAA Safe Harbor (18 identifiers)
Consent modelBroad consent
Primary modalitiesProteomic / Clinical / Longitudinal
Follow-up durationUp to 60 months
FormatParquet, FHIR R4, CSV/TSV
Last updatedQ3 2025

Ready to access this dataset?

Submit a data brief and our team will confirm availability, cohort fit, and delivery timeline.

Request Data Access Talk to our team